Bridgepoint $BPT weighs $1B MyDefence sale; revenue set to double
Original: Bridgepoint weighs $1bn sale of anti-drone group guarding World Cup sites View original →
A roughly $1B valuation is now attached to Bridgepoint $BPT portfolio company MyDefence, a Danish counter-drone technology group. The Financial Times reported on June 14, 2026 that Bridgepoint is preparing a possible sale, has hired an adviser, and is looking toward an auction near year-end. People cited by the FT said MyDefence sales are poised to more than double this year.
The story clears the Tier-1 M&A threshold because the potential transaction value is above $500M. It is not yet a signed deal. The reported process is still exploratory, and Bridgepoint and MyDefence declined to comment to the FT. The market signal is the price discovery around private defence technology assets as military, infrastructure, and event-security buyers increase spending on counter-UAS systems.
Bridgepoint’s ownership is supported by primary company material. In a June 3, 2024 release, Bridgepoint said Bridgepoint Development Capital IV became MyDefence’s new majority shareholder and would support the company with research-and-development investment and production expansion. Financial terms of that 2024 investment were not disclosed.
MyDefence’s current demand backdrop is tied to large-event and military drone risk. In a company update on FIFA World Cup 2026 preparations, MyDefence said it is working with the U.S. Department of Homeland Security on counter-UAS drone detection and airspace awareness. The company describes World Cup venues as a complex airspace environment involving commercial drones, media coverage, emergency services, public-safety aviation, and unauthorized or hostile unmanned aircraft.
The FT report also cited sector comparables: Dutch drone-detection company Robin Radar Systems is exploring a sale at about $2B, while Bridgepoint is raising a new flagship fund of about €7.5B. The next data points are whether Bridgepoint formally launches an auction, which strategic defence contractors or buyout firms submit indications of interest, and whether MyDefence’s 2026 revenue growth matches the reported more-than-doubling trajectory.
Not investment advice. Verify all figures with primary sources before acting.
Related Articles
GSK $GSK agreed to acquire Nuvalent $NUVL for $10.6B in cash, offering $124 a share and a 40% premium to Nuvalent’s prior close. The transaction gives GSK two late-stage lung-cancer assets under U.S. FDA review for 2026 approvals.
Hugo Boss shares rose 8% after Frasers Group launched a $2B takeover offer, according to CNBC. Frasers already owns roughly 26% of the German fashion group, making the bid a material European retail M&A event.
Greg Abel, Warren Buffett's successor at Berkshire Hathaway ($BRK.B), has invested approximately $2.8 billion in Delta Air Lines ($DAL) despite surging fuel costs pressuring the sector — a direct reversal of Buffett's 2020 pandemic-era exit from all airline positions. On the same day, Appaloosa Management disclosed it had sold its entire positions in Delta, American Airlines ($AAL), and United Airlines ($UAL).